Edgewise Therapeutics (EWTX) Times Interest Earned (2020 - 2025)
Edgewise Therapeutics (EWTX) posted Times Interest Earned of -$14.73 for Q4 2025, down 48.8% sequentially from -$9.9 in Q4 2024, and down 48.8% YoY from -$28.77 in Q4 2024.
Edgewise Therapeutics (EWTX) Times Interest Earned (2020 - 2025) Analysis & Trends
Edgewise Therapeutics has reported Times Interest Earned for 6 years, with the latest figure at -$14.73 in Q4 2025.
- Quarterly Times Interest Earned fell 48.8% year-over-year to -$14.73 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$50.37 (down 45.88% YoY) and the FY2025 annual result came in at -$0.75, down 26.01% from the prior year.
- Times Interest Earned slipped to -$14.73 in Q4 2025 per EWTX's latest filing, from -$9.9 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$3.61 in Q2 2023 and troughed at -$638.91 in Q4 2023.
- A 5-year average of -$72.56 and a median of -$22.78 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2021 and 2024: Times Interest Earned sank 12585.77% in 2021, then jumped 98.45% in 2024.
- Over 5 years, Times Interest Earned stood at -$90.94 in 2021, then surged by 43.8% to -$51.11 in 2022, then plunged by 1150.09% to -$638.91 in 2023, then surged by 98.45% to -$9.9 in 2024, then plunged by 48.8% to -$14.73 in 2025.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$14.73, -$9.9, and -$35.75 for Q4 2025, Q4 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Edgewise Therapeutics | 4.76 Bn | 4.76 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.73 |
| Dec 31, 2024 | -9.90 |
| Jun 30, 2024 | -35.75 |
| Mar 31, 2024 | -5.45 |
| Dec 31, 2023 | -638.91 |
| Sep 30, 2023 | -22.78 |
| Jun 30, 2023 | -3.61 |
| Mar 31, 2023 | -3.62 |
| Dec 31, 2022 | -51.11 |
| Sep 30, 2022 | -25.90 |
| Jun 30, 2022 | -36.09 |
| Mar 31, 2022 | -4.49 |
| Dec 31, 2021 | -90.94 |
| Dec 31, 2020 | -0.72 |